Bibliographic details
Schwander B, Ravera S, Giuliani G, Nuijten M, Walzer S. Cost comparison of second-line treatment options for late stage non-small-cell lung cancer: cost analysis for Italy. ClinicoEconomics and Outcomes Research 2012; 4(1): 237-243